Contract award
TAKEDA PHARMACEUTICALS AMERICA, INC.
LANADELUMAB-FLYO 150MG/ML INJ, SYRINGE,2ML (TAKHZYRO)
- PIID
- 36C26024F0417
- Award key
- CONT_AWD_36C26024F0417_3600_V797D50492_3600
- Recipient UEI
- DDEVYUAXJ624
- Parent award
- CONT_IDV_V797D50492_3600
- Source as of
- —
Current award value
$192,5083
Obligated to date
$192,5082
Potential with options
$192,5083
- Awarding agency
- Department of Veterans AffairsDepartment of Veterans Affairs
- Contractor
- TAKEDA PHARMACEUTICALS AMERICA, INC.
- Place of performance
- Rockville, Maryland
- Set-aside
- None
- Pricing
- Firm Fixed Price
- Competition
- Full and Open Competition1 offers received
- Period of performance
- May 20, 2024 — May 19, 2025Through May 19, 2025 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | May 17, 2024 | Initial award | $221,342.40 | $192,508.19 |
| P00001 | Oct 5, 2026 | C | -$28,834.21 | $192,508.19 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| contractor_id | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| current_award_value | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| naics_code | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| potential_award_value | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| psc_code | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
| total_obligated | USAspending.gov | — | Oct 10, 2026 | usaspending_contract_csv@2026.08.2 | 479175f74727 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Oct 10, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.